Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by TheeRookon Feb 05, 2021 3:21pm
220 Views
Post# 32486861

RE:VPT BOOSTERS IGNITED

RE:VPT BOOSTERS IGNITED But that alone will not move the SP.. Only Sales or a good investors relation company will.

VENTRIPOINT HIRES MARKETSMART COMMUNICATIONS TO PROVIDE INVESTOR RELATIONS SERVICES

Ventripoint Diagnostics Ltd. has entered into an investor relations agreement with MarketSmart Communications Inc. pursuant to which MarketSmart will provide investor relations (IR) services to Ventripoint. The IR agreement is for an initial term of six months commencing on Feb. 5 , 2021, with an option for renewal. Either party may terminate the agreement for any reason, with or without cause, on 15-day written notice to the other.

Pursuant to the IR agreement, MarketSmart will be paid a fee of $9,500 per month, plus applicable taxes, and will be granted stock options to purchase 400,000 common shares of Ventripoint at a price of 25 cents per share for a term of two years in accordance with the Ventripoint's stock option plan and vesting quarterly over one year

salstockpickz wrote:
great investment! great product! great managment! BY OUT around the corner, hold tight

GL longs



<< Previous
Bullboard Posts
Next >>